Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes
2015 ◽
Vol 7
(319)
◽
pp. 319ra205-319ra205
◽
2017 ◽
Vol 5
(1)
◽
pp. e000391corr1
2018 ◽
Vol 32
(12)
◽
pp. 1100-1104
◽
2017 ◽
Vol 9
(4)
◽
pp. 366-373
◽
Keyword(s):
2017 ◽
Vol 33
(2)
◽
pp. 309-315
◽
2004 ◽
Vol 14
(17)
◽
pp. 4445-4448
◽
Keyword(s):
2020 ◽
Vol 32
(1)
◽
pp. 996-999